SUMMARY The toxic and inotropic effects of a rapid-acting cardiac glycoside, acetylstrophanthidin (ACS), administered as a rapid i.v. bolus was compared in six healthy adult (age 2-3 years) and seven senescent (age 12-14 years) beagles. In the conscious state no age difference was observed in the dosage of ACS at which toxicity, defined as ventricular tachycardia (VT), occurred. Serum levels of ACS at toxicity were 70 ± 15 ng/ml in the senescent and 65 ± 12 ng/ml in the adult (NS). On a separate occasion, the inotropic effect, dP/dt/P50, and the toxic end point were measured in the anesthetized state. As in the awake state, no age difference was seen in the dosage to VT. The control dP/dt/P,, measured with a left ventricular Millar catheter during brief periods of right ventricular pacing at 250 beats/min was not age related. However, the increase in contractility in response to ACS was two times greater in the adult than the senescent (p < 0.001). This difference persisted when A-blockade was effected with practolol. Thus, in senescence, while glycoside toxicity is unaltered, the inotropic efficacy of ACS is significantly diminished. This age difference in inotropy cannot be attributed to an age difference in serum levels of the drug or in sympathetic tone. Additional studies indicated that glycoside inhibition of Na+-K+ ATPase isolated from these dogs was not age related, suggesting that the mechanism for the diminished inotropic response is distal to the inhibition of this receptor enzyme.
AGE is an important determinant in the response to cardiac glycosides. Most mammalian species exhibit altered sensitivity to the inotropic and toxic effects of digitalis preparations in the neonatal period compared with the young adult. [1] [2] [3] [4] These differences have been attributed to both maturational changes in the volume distribution of glycosides5 6 and to different effects of these agents at the cellular level. 7 8 With advanced age, many physiologic changes occur in the cardiovascular system in both man and animals.9 10 Although the performance of cardiac muscle isolated from the heart of senescent animals in many ways is indistinguishable from that of its adult counterpart, the response to some interventions that impose a stress on the excitation-contraction system is altered in senescent myocardium.11 In particular, the inotropic response to ouabain is diminished in senescent myocardium when compared with the adult, while the response to an increase in [Ca++] in the bathing fluid or to paired pacing is not age related.'2
The purpose of the present study is to extend these observations on the effect of advanced age on the response to cardiac glycosides in isolated cardiac muscle to the intact organism. Specifically, we compare the toxic and inotropic responsiveness to a rapidacting cardiac glycoside in intact, senescent dogs. While the glycoside is used primarily to elucidate agerelated alterations that occur in the cardiovascular system as a result of advanced age, the study may also have practical implications. The marked increase in the prevalence of cardiovascular pathology in aged 1 
Materials and Methods
The effects of bolus injections of acetylstrophanthidin (ACS) were studied in six healthy adult (2-3 years old, 12 ± 0.8 kg) and seven senescent (12-14 years old, 11.1 i 0.6 kg) female beagles that were free of gross cardiovascular pathology. ACS was used because of its rapid onset and short duration of action. The dogs were studied in each of three protocols. We determined 1) the toxic threshold in awake, unanesthetized dogs; 2) the toxic threshold and inotropic response in the anesthetized state; and 3) the inotropic response at toxicity in the presence of d blockade during anesthesia. Individual studies in any single dog were separated by at least 2 weeks. In addition, glycoside inhibition of Na+-K+ ATPase was measured in microsomal fractions from many of these hearts when the dog was sacrificed later.
Toxic Threshold in Awake, Unanesthetized Dogs Standard surface ECG leads were attached to the skin, and lead I or II was monitored. ACS was administered as a rapid bolus through an indwelling peripheral venous catheter. The ACS concentration of the initial bolus was 20 mg/kg, which was increased by 5-Ag/kg increments every 30 minutes until ventricular tachycardia (VT) occurred. VT was defined as five or more consecutive premature ventricular complexes. Blood was drawn for the determination of ACS concentration before each injection and at the toxic end point, VT. When VT was reached, diphenylhydantoin was given in order to preserve the dog for future studies. Serum ACS concentration was determined by standard radioimmunoassay technique. ' After the toxic threshold during anesthesia had been determined in a given dog, the animal was again anesthetized and instrumented. Beta-adrenergic blockade was effected with practolol, 2-4 mg/kg i.v.
The efficacy of the block was tested and considered complete when there was no greater than a 5 beats/min increase in heart rate response to a 5-,ug bolus i.v. injection of isoproterenol. This concentration of isoproterenol in the absence of : blockade resulted in an increase of heart rate of 35 ± 12 beats/min. During /B blockade, ACS was given in a concentration near the previous toxic threshold and increased by 10-,g/kg increments every 30 minutes until VT occurred. Hemodynamic parameters were then measured during pacing at 200 beats/min.
In addition to measurements of EDP, LVP and dP/dtmax, the ratio of dP/dt to LVP at a ventricular pressure of 50 mm Hg was calculated (dP/dt/P50). This ratio has been previously assessed as an index of contractility17-20 and was used in the present study to measure the inotropic response to ACS. The data reported are the mean of at least five beats during the control period, before a bolus of ACS, and at the peak inotropic response to ACS, which occurred 3-10 minutes after the injection.
Na+-K+ ATPase Inhibition
At a later date, several dogs used in this study were sacrificed and glycoside inhibition of Na+-K+ ATPase isolated from these hearts was determined. Microsomes containing (Na+-K+)-adenosine triphosphatase were isolated by the method of Matsui and Schwartz.2' The ouabain-sensitive and total ATPase activities in this preparation were determined at 22 1 The heart rate in the resting, awake dogs was not age related and was 88.6 ± 4.2 beats/min in the seven senescent beagles and was 92.9 4.0 beats/min in the six adult beagles. In response to ACS, a series of dysrhythmias, including sinus bradycardia, junctional beats and supraventricular tachycardia, occurred before VT, but there was no age difference in the sequence or magnitude of these subtoxic responses. Table 1 lists the size of the bolus injection at which VT fig. 2B ). This value was considered the control for the effect of a subsequent bolus injection.
The peak responses of LVP, dP/dtmax and dP/dt/P50 to ACS are given in figure 3 . EDP did not change from control in either age group in response to ACS. The maximal increase in peak LVP in response to ACS was not age related ( fig. 3) . The dose-response relationship of dP/dtmax and dP/dt/P50 was significantly greater (p < 0.01 and p < 0.005, respectively) in the adult than in the senescent group (nested analysis of variance). Age differences of a similar magnitude were observed when the response in these parameters was compared as a percentage of the control value. The approximately twofold greater inotropic response in the adult group at the higher ACS concentrations ( fig. 3 ) persisted when the maximum response in each dog was compared independent of the ACS dosage. As 
The total (Mg2' dependent) and specific (Na -K) ATPase activities measured at 22°C in hearts averaged 3 ,mol/mg/hr (n = 3) in senescent hearts (NS). Figure  4 compares the effects of the glycoside on (Na+-K+)-ATPase. In both age groups the effect of ouabain begins to appear at 10-7M and maximum levels of inhibition are achieved between 10-' and 10-4M. There was no age difference in the extent of inhibition expressed as a percent of total inhibition over the entire range of concentrations of the glycoside. Discussion VT, as an index of toxicity, has been used previously and the range of ACS concentrations over which VT occurred is similar in this study to that reported for other adult dogs.4 23 There was no difference in the threshold for ACS toxicity, defined as VT, in the senescent dogs compared with the adult dogs (table 1) .
In contrast to the similarity in toxic threshold, the intact senescent dogs had diminished inotropic responsiveness to ACS compared with the adult dogs ( fig. 3  and table 2 ). The inotropic index used in this study was the ratio of left ventricular isovolumic dP/dt to developed pressure at 50 mm Hg (dP/dt/P,,).
Changes in this index have been shown to be relatively independent of preload and afterload changes.'7-20 The greater ACS induced increase in dP/dt/P,o in the adult was accompanied by a similar age-dependent difference in the change in dP/dtmax, with no age difference in the response in LVP. EDP was not changed in either age group in response to ACS. These changes when examined collectively indicate a greater inotropic response in the adult than in the senescent dog.
The increase in contractility due to cardiac glycosides in the adult dogs during anesthesia in this study is similar to previously reported data.24 27 senescent dogs, for when analyzed at toxicity, the inotropic response was significantly greater in the adult than the senescent group. Stated in other terms, in senescence, the same risk of toxicity for a given serum level existed, but the inotropic benefit from ACS was reduced. In man, however, serum levels of cardiac glycosides for a given dose have been shown to be increased in advanced age.29 30 Information regarding the inotropic or toxic effect of a given serum level remains anecdotal. '3' 14 In summary, in healthy senescent beagles, the threshold for VT was unaltered, but the inotropic response to ACS was diminished when compared with that in the healthy adult beagle. This decrease in the inotropic response was not a function of age differences in drug elimination from the serum, sympathetic tone or glycoside inhibition of Na+-K+ ATPase.
